Company Profile

Movano Stock Price, News & Analysis

Ticker:
MOVE
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Movano is followed within the biotech universe for its exposure to catalyst-driven execution.

Stock performance

21.43 USD (-6.70%)

Close

Last updated: June 23, 2026 at 00:00

42.45M USD

Market cap

Why the stock is moving

MOVE is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Movano is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Movano is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Movano follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Movano sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Movano (MOVE)?

    Movano (MOVE) most recently closed at 21.43 USD, a -6.70% move versus the previous session.

    What is the market cap of Movano (MOVE)?

    Movano currently has a market capitalization of 42.45M USD on BioPharmSignal.

    What does Movano do?

    Movano is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    On which exchange is MOVE stock listed?

    Movano (MOVE) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Movano is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.

    What is Movano?

    Movano is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

    Which conditions is Movano targeting with Movano?

    Movano is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    What is Investors?

    Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.